pricing
Senate puts forward bipartisan bill to lower price of drugs
July 24, 2019Research and Development PBMs, Senate, USA, access, bipartisan, pharma, pricing
The Senate Finance Committee has introduced a bipartisan bill that aimed at lowering the prices Medicare pays for pharmaceutical drugs. …
Trump says executive order will ensure US will pay lowest prices in the world for drugs
July 8, 2019Sales and Marketing Trump, US, executive order, pharma, politics, pricing
President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …
Prices hiked on 3,400 drugs in first half of 2019
July 4, 2019Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing
There have been price hikes on more than 3,400 drugs in the United States in the first six months of …
MPs discuss breaking Vertex’s IP rights to bring Orkambi to UK
June 11, 2019Research and Development Orkambi, Vertex, access, house of commons, pharma, pricing
MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the deadlock and …
Top Ten most popular articles on Pharmafile.com this week!
May 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing
The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …
UK government refuses to sign up to WHO pricing transparency resolution
May 29, 2019Research and Development WHA, WHO, access, health UK, pharma, pricing
The UK government has refused to sign up to a global resolution on transparency in drug pricing which urges governments …
Novartis’ $2.15m SMA drug Zolgensma becomes most expensive FDA-approved therapy
May 28, 2019Manufacturing and Production AveXis, FDA, Zolgensma, access, drugs, pricing, sma
The FDA has approved Novartis subsidiary AveXis’ $2.15 million gene therapy Zolgensma for children with spinal muscular atrophy (SMA). The …
US States allege 20 generic drugmakers fixed prices of generic drugs
May 13, 2019Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing
Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …
The price of access: Can the NHS afford Orkambi?
April 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing
The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
ICR calls for faster access to innovative cancer drugs
April 25, 2019Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing
The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …
Indian government set to colour code generic medicines
March 4, 2019Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales
As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …
J&J to include prices in drug ads on TV
February 8, 2019Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing
US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …
Pharma chiefs will testify at Senate hearing on rising drug prices
February 7, 2019Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …
Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free
February 5, 2019Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing
Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …
Cost of insulin doubled between 2012 and 2016
January 23, 2019Research and Development USA, healthcare, insulin, insurance, pricing
The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …
